Dec 01, 2020 / 01:00PM GMT
Vijay Muniyappa Kumar - Evercore ISI Institutional Equities, Research Division - MD
Okay. Thanks, everyone, for joining us this morning. It's a real pleasure. We have Boston Scientific to kick off our Annual Healthcare Conference. It is a relief that this is the last health care conference. No more conferences until the holiday season. So we know representing the company, we have the CEO and Chairman, Mike Mahoney. And from IR, we have Susie Lisa and Lauren Tengler. Real pleasure to have all of you this morning.
Questions and Answers:
Vijay Muniyappa Kumar - Evercore ISI Institutional Equities, Research Division - MDMike, maybe I'll start with a big-picture question. I saw the divestiture this morning, so congrats on the transaction. Before we get there, this has been an unusual year for Boston. Stock's been choppy. We've had some 2 steps forward, 1 step backward, if you will. A question that I've been getting is has anything changed at Boston? If you look at the stock, this has been such a home run over the last 5 years. Has something changed for Boston?